RaySearch Laboratories (Q2 Review): H2 needs to deliver - Redeye
Bildkälla: Stockfoto

RaySearch Laboratories (Q2 Review): H2 needs to deliver - Redeye

Q2 was weak, as already known from the July profit warning, mainly due to several larger US orders being delayed. With the first delayed orders now materialising and RaySearch reiterating its +25% EBIT margin target for 2026, we expect a significantly stronger H2.

Q2 was weak, as already known from the July profit warning, mainly due to several larger US orders being delayed. With the first delayed orders now materialising and RaySearch reiterating its +25% EBIT margin target for 2026, we expect a significantly stronger H2.
Börsvärldens nyhetsbrev